These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 8784099)

  • 1. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
    Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
    Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daytime plasma melatonin levels in male hypogonadism.
    Ozata M; Bulur M; Bingol N; Beyhan Z; Corakci A; Bolu E; Gundogan MA
    J Clin Endocrinol Metab; 1996 May; 81(5):1877-81. PubMed ID: 8626851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome.
    Ozata M; Ozisik G; Caglayan S; Yesilova Z; Bingöl N; Saglam M; Turan M; Beyhan Z
    Horm Metab Res; 1998 May; 30(5):266-71. PubMed ID: 9660087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone-binding globulin changes with androgen replacement.
    Plymate SR; Leonard JM; Paulsen CA; Fariss BL; Karpas AE
    J Clin Endocrinol Metab; 1983 Sep; 57(3):645-8. PubMed ID: 6683724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
    Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
    Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor concentrations in seminal plasma from patients with hypogonadism--changes after hormone replacement.
    Fuse H; Okumura M; Sakamoto M; Kazama T; Katayama T
    Urol Int; 1994; 52(1):9-13. PubMed ID: 8140686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
    Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal leptin secretion is intact in male hypogonadotropic hypogonadism and is not influenced by exogenous gonadotropins.
    Kilciler G; Ozata M; Oktenli C; Sanisoglu SY; Bolu E; Bingol N; Kilciler M; Ozdemir IC; Kutlu M
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5023-9. PubMed ID: 12414867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a).
    von Eckardstein A; Kliesch S; Nieschlag E; Chirazi A; Assmann G; Behre HM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3367-72. PubMed ID: 9329370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular function during puberty and young adulthood in patients with Klinefelter's syndrome with and without spermatozoa in seminal fluid.
    Rohayem J; Nieschlag E; Zitzmann M; Kliesch S
    Andrology; 2016 Nov; 4(6):1178-1186. PubMed ID: 27611179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oestrogen administration on plasma testosterone, FSH and LH levels in patients with Klinefelter's syndrome and normal men.
    Smals AG; Kloppenborg PW; Lequin RM; Benraad TJ
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):765-83. PubMed ID: 4479709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Event-related brain potentials in male hypogonadism.
    Ozata M; Odabasi Z; Caglayan S; Beyhan Z; Vural O; Ozdemir C
    J Endocrinol Invest; 1999; 22(7):508-13. PubMed ID: 10475147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of serum testosterone levels to human chorionic gonadotrophin stimulation in patients with Klinefelter's syndrome after long-term androgen replacement therapy.
    Fukutani K; Ishida H; Shinohara M; Minowada S; Niijima T; Isurugi K
    Int J Androl; 1983 Feb; 6(1):5-11. PubMed ID: 6404842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.